InterCure Ltd.
INCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $276 | $213 | $525 | $772 |
| - Cash | $78 | $101 | $233 | $196 |
| + Debt | $211 | $196 | $255 | $109 |
| Enterprise Value | $409 | $307 | $547 | $684 |
| Revenue | $239 | $356 | $389 | $220 |
| % Growth | -32.8% | -8.5% | 76.9% | – |
| Gross Profit | $30 | $105 | $155 | $91 |
| % Margin | 12.7% | 29.6% | 39.9% | 41.5% |
| EBITDA | -$51 | -$24 | $70 | $31 |
| % Margin | -21.5% | -6.7% | 18.1% | 14.2% |
| Net Income | -$68 | -$62 | $45 | $5 |
| % Margin | -28.4% | -17.4% | 11.5% | 2.1% |
| EPS Diluted | -1.42 | -1.36 | 0.99 | 0.11 |
| % Growth | -4.4% | -237.4% | 800% | – |
| Operating Cash Flow | -$67 | -$54 | $51 | $25 |
| Capital Expenditures | -$4 | -$3 | -$20 | -$14 |
| Free Cash Flow | -$71 | -$56 | $32 | $11 |